{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:57:47Z","timestamp":1776959867928,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011848","name":"Novo Nordisk Canada Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009881","name":"Breakthrough T1D Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019518","name":"Eli Lilly Canada Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008985","name":"Diabetes Quebec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008985","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.diabet.2025.101667","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:32:34Z","timestamp":1750429954000},"page":"101667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["In adults living with type 1 diabetes, additional autoimmune diseases are associated with more chronic complications and depression. A BETTER registry analysis"],"prefix":"10.1016","volume":"51","author":[{"given":"Cassandra A.A.","family":"Locatelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryem K.","family":"Talbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Messier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Grou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Lebbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Mulvihill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sophie","family":"Brazeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4706-5170","authenticated-orcid":false,"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2025.101667_bib0001","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"The diabetes control and complications trial (DCCT)\/epidemiology of diabetes interventions and complications (EDIC) Study research Group. Intensive diabetes treatment and cardiovascular outcomes in T1D: the DCCT\/EDIC study 30-year follow-up","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101667_bib0002","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jcjd.2022.05.010","article-title":"Self-reported severe and nonsevere hypoglycemia in T1D: population surveillance through the BETTER patient engagement registry: development and baseline characteristics","volume":"46","author":"Brazeau","year":"2022","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.diabet.2025.101667_bib0003","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/dme.14216","article-title":"The cognitive and psychological effects of living with T1D: a narrative review","volume":"37","author":"van Duinkerken","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2025.101667_bib0004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/1753-0407.12856","article-title":"High prevalence of comorbid autoimmune diseases in adults with T1D from the HealthFacts database","volume":"11","author":"Bao","year":"2019","journal-title":"J Diabetes"},{"key":"10.1016\/j.diabet.2025.101667_bib0005","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/jc.2016-2478","article-title":"Autoimmune diseases in children and adults with T1D from the T1D exchange clinic registry","volume":"101","author":"Hughes","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2025.101667_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00476","article-title":"Increasing co-occurrence of additional autoimmune disorders at diabetes type 1 onset among children and adolescents diagnosed in years 2010\u20132018\u2014Single-center study","volume":"11","author":"G\u0142owi\u0144ska-Olszewska","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabet.2025.101667_bib0007","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2337\/dc19-2429","article-title":"on behalf of the FinnDiane Study Group. Every fifth individual with T1D suffers from an additional autoimmune disease: a Finnish nationwide study","volume":"43","author":"M\u00e4kimattila","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101667_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110031","article-title":"Comorbid autoimmune diseases and burden of diabetes-related complications in patients with T1D from a Mediterranean area","volume":"191","author":"Gimenez-Perez","year":"2022","journal-title":"Diabetes Res Clin Pr"},{"key":"10.1016\/j.diabet.2025.101667_bib0009","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/jwh.2019.7935","article-title":"Sex Differences in autoimmune multimorbidity in t1d mellitus and the risk of cardiovascular and renal disease: a longitudinal study in the United States, 2001\u20132017","volume":"29","author":"Rogers","year":"2020","journal-title":"J Women\u2019s Health"},{"key":"10.1016\/j.diabet.2025.101667_bib0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1071\/PY21273","article-title":"Experiences of adults with adult-onset T1D: a cross-sectional study","volume":"28","author":"Berkovic","year":"2022","journal-title":"Aust J Prim Health"},{"key":"10.1016\/j.diabet.2025.101667_bib0011","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00125-024-06086-8","article-title":"Autoimmune comorbidity in T1D and its association with metabolic control and mortality risk in young people: a population-based study","volume":"67","author":"Samuelsson","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2025.101667_bib0012","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/ard.2006.068130","article-title":"Rheumatoid arthritis is associated with a high prevalence of hypothyroidism that amplifies its cardiovascular risk","volume":"67","author":"Raterman","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.diabet.2025.101667_bib0013","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12872-024-03963-3","article-title":"Risk for cardiovascular disease development in rheumatoid arthritis","volume":"24","author":"Bedekovi\u0107","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.diabet.2025.101667_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmjment-2024-301252","article-title":"Elucidating the bidirectional association between autoimmune diseases and depression: a systematic review and meta-analysis","volume":"27","author":"Li","year":"2024","journal-title":"BMJ Ment Health"},{"key":"10.1016\/j.diabet.2025.101667_bib0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12664-021-01215-2","article-title":"Celiac disease poses significant risk in developing depression, anxiety, headache, epilepsy, panic disorder, dysthymia: a meta-analysis","volume":"40","author":"Sharma","year":"2021","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.diabet.2025.101667_bib0016","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/dme.12205","article-title":"Compromised quality of life in patients with both T1D mellitus and coeliac disease","volume":"30","author":"Bakker","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2025.101667_bib0017","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2213-8587(14)70248-7","article-title":"Risk of all-cause mortality and vascular events in women versus men with T1D: a systematic review and meta-analysis","volume":"3","author":"Huxley","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2025.101667_bib0018","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2025.101667_bib0019","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jad.2024.09.088","article-title":"Depression prevalence, screening, and treatment in adult outpatients with type 1 and type 2 diabetes: a nationally representative cross-sectional study (National Ambulatory Medical Care Survey 2014\u20132019)","volume":"368","author":"Chieh","year":"2025","journal-title":"J Affect Disord"},{"key":"10.1016\/j.diabet.2025.101667_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0009922812459950","article-title":"Mental health issues in adolescents and young adults with t1d: prevalence and impact on glycemic control","volume":"52","author":"Bernstein","year":"2013","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.diabet.2025.101667_bib0021","first-page":"155","article-title":"Glucose concentrations of <3.0 mmol\/l (54 mg\/dl) should be reported in clinical trials: a joint position statement of the american diabetes association and the european association for the study of diabetes","volume":"40","author":"Group","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101667_bib0022","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.diabet.2025.101667_bib0023","unstructured":"World Health Organization. The World Health Organization-five well-being index (WHO-5). 2024."},{"key":"10.1016\/j.diabet.2025.101667_bib0024","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diacare.28.3.626","article-title":"Assessing psychosocial distress in diabetes: development of the diabetes distress scale","volume":"28","author":"Polonsky","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101667_bib0025","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jcjd.2020.10.010","article-title":"The prevalence of autoimmune diseases in longstanding diabetes: results from the Canadian Study of Longevity in adults with T1D","volume":"45","author":"Cardinez","year":"2021","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.diabet.2025.101667_bib0026","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2337\/dc10-1989","article-title":"Effect of continuous glucose monitoring on hypoglycemia in T1D","volume":"34","author":"Battelino","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101667_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4158\/EP-2017-0032","article-title":"Self-blood glucose monitoring underestimates hyperglycemia and hypoglycemia as compared to continuous glucose monitoring in type 1 and type 2 diabetes","volume":"24","author":"Mangrola","year":"2018","journal-title":"Endocr Pr"},{"key":"10.1016\/j.diabet.2025.101667_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101118","article-title":"Unraveling the concepts of distress, burnout, and depression in T1D: a scoping review","volume":"40","author":"Kiriella","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.diabet.2025.101667_bib0029","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S0033291709990213","article-title":"Age differences in major depression: results from the national comorbidity surveys replication (NCS-R)","volume":"40","author":"Kessler","year":"2010","journal-title":"Psychol Med"},{"key":"10.1016\/j.diabet.2025.101667_bib0030","doi-asserted-by":"crossref","first-page":"11631","DOI":"10.2147\/JIR.S499473","article-title":"Important role of mitochondrial dysfunction in immune triggering and inflammatory response in rheumatoid arthritis","volume":"17","author":"Li","year":"2024","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.diabet.2025.101667_bib0031","article-title":"Mitochondria dysfunction: a trigger for cardiovascular diseases in systemic lupus erythematosus","volume":"144","author":"Wang","year":"2025","journal-title":"Interna Immunopharmacol"},{"key":"10.1016\/j.diabet.2025.101667_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107322","article-title":"Inflamed\u201d depression: a review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression","volume":"207","author":"Yin","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.diabet.2025.101667_bib0033","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/jnnp-2019-320912","article-title":"Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials","volume":"91","author":"Bai","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.diabet.2025.101667_bib0034","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1210\/clinem\/dgac278","article-title":"Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an endocrine society clinical practice guideline","volume":"107","author":"Korytkowski","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2025.101667_bib0035","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.amjmed.2019.12.026","article-title":"Systemic treatment with glucocorticoids is associated with incident hypoglycemia and mortality: a historical prospective analysis","volume":"133","author":"Khanimov","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.diabet.2025.101667_bib0036","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1097\/MS9.0000000000002745","article-title":"Frexalimab (SAR441344) as a potential multiautoimmune disorder tackling mAB targeting the CD40-CD40L pathway undergoing clinical trials: a review","volume":"86","author":"Fatima","year":"2024","journal-title":"Ann Med Surg (L)"},{"key":"10.1016\/j.diabet.2025.101667_bib0037","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.2337\/dc08-0720","article-title":"Barriers to physical activity among patients with T1D","volume":"31","author":"Brazeau","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2025.101667_bib0038","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S2213-8587(17)30014-1","article-title":"Exercise management in T1D: a consensus statement","volume":"5","author":"Riddell","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2025.101667_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101277","article-title":"Self-reported haemoglobin A1c highly agrees with laboratory-measured haemoglobin A1c among adults living with T1D: a BETTER registry study","volume":"48","author":"Wu","year":"2022","journal-title":"Diabetes Metab"},{"issue":"Suppl.:S37\u201347","key":"10.1016\/j.diabet.2025.101667_bib0040","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363625000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363625000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:04:31Z","timestamp":1763762671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363625000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1262363625000618"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101667","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In adults living with type 1 diabetes, additional autoimmune diseases are associated with more chronic complications and depression. A BETTER registry analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101667","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101667"}}